# Anavo Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anavo-therapeutics

- Industry: Biotechnology
- Headquarters: Leiden, Netherlands
- Website: www.anavotx.com
- Total disclosed funding: $33M
- Latest round: Seed (May 2, 2023)
- Investors on record: 5

## About

Based in Leiden, Netherlands, and founded in 2020, Anavo Therapeutics BV develops therapeutic programs that discover the potential of human phosphatase biology. In May 2023, Anavo Therapeutics BV raised EUR 8.5 million in seed funding led by MRL Ventures Fund, with participation from Bioqube Ventures, Inkef Capital B.V., M Ventures, and Taiho Ventures.

Anavo Therapeutics BV platform develops therapeutic programs to establish pipelines across several indications, thereby, providing clients with scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the potential of phosphatase-targeted allosteric modulators.

The company generates revenue through the sale of the developed therapies to pharmaceutical companies.

Anavo Therapeutics BV plans to use the May 2023 funding to support the advancement of its novel phosphatase modulators.

## Funding rounds

- Seed, May 2, 2023, $9.4M — Inkef, Taiho Ventures, M Ventures, MRL Ventures Fund, Bioqube Ventures
- Seed, Apr 22, 2021, $24M — Inkef, Taiho Ventures, M Ventures, Bioqube Ventures

## Investors

- Inkef (https://capitalatlas.ai/funds/inkef) — Seed
- Taiho Ventures (https://capitalatlas.ai/funds/taiho-ventures) — Seed
- M Ventures (https://capitalatlas.ai/funds/m-ventures) — Seed
- Bioqube Ventures (https://capitalatlas.ai/funds/bioqube-ventures) — Seed
- MRL Ventures Fund (https://capitalatlas.ai/funds/mrl-ventures-fund) — Seed